-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $32

Benzinga·11/10/2026 14:35:27
Listen to the news
Jefferies analyst Maury Raycroft initiates coverage on City Therapeutics (NASDAQ:CTY) with a Buy rating and announces Price Target of $32.